Keppra Shortage Update: What Patients Need to Know in 2026

For people living with epilepsy, the supply of their anti-seizure medication isn't just a matter of convenience — it's a matter of safety. Keppra (levetiracetam) has experienced supply disruptions in the past, and patients understandably want to know: what is the current status, and what should I do to prepare?

Current Keppra Shortage Status in 2026

As of early 2026, Keppra (levetiracetam) does not appear on the FDA's official drug shortage database. The U.S. supply is generally considered stable, with multiple generic manufacturers producing immediate-release tablets, extended-release tablets, and oral solution. This redundancy in the manufacturing base provides some protection against single-source disruptions.

However, patients and caregivers should not interpret "no official shortage" as "no availability problems." Localized stock gaps — where a specific pharmacy in your area happens to be out of the strength you need — can still occur at any time. The FDA only declares an official shortage when the national supply is insufficient to meet demand; individual pharmacy stock-outs happen for other reasons.

Past Keppra Shortages: What Happened

Levetiracetam has experienced documented supply disruptions before. The most notable was in early 2020, when the FDA worked with manufacturers to address a serious supply situation affecting both immediate-release and extended-release tablets. The Epilepsy Foundation actively communicated with the FDA during that period. The situation was ultimately resolved as manufacturers increased production.

In 2024, a survey of epilepsy patients in the UK found that 62.8% had experienced difficulty obtaining levetiracetam — a striking figure even in the absence of an officially declared shortage. Researchers noted that "the medicines people struggled to find weren't listed nationally as being in short supply," highlighting how official shortage lists can undercount the real patient impact.

Why Does Levetiracetam Experience Supply Gaps?

Several factors contribute to levetiracetam availability challenges:

High demand: With more than 6 million U.S. prescriptions per year, levetiracetam's popularity means any supply hiccup is immediately felt by a large number of patients.

Multiple formulations: The drug comes in many strengths and forms (250 mg, 500 mg, 750 mg, 1000 mg tablets; oral solution; extended-release tablets). Supply disruptions for one strength don't always affect others.

Generic market dynamics: While multiple generic manufacturers produce levetiracetam, most retail pharmacies stock only one generic at a time. If that manufacturer has a production disruption, the pharmacy's supply runs out even though alternatives exist.

Just-in-time pharmacy inventory: Large pharmacy chains minimize storage costs by ordering small, frequent batches. This leaves little buffer when supply disruptions occur.

What Should Patients Do to Prepare?

Even in the absence of an active shortage, patients taking levetiracetam should take these proactive steps:

Refill early: Fill your prescription when you have 7–10 days remaining, not when you're on your last pill.

Request a 90-day supply: If your insurer allows it, a 90-day mail-order supply provides a larger buffer against stock gaps.

Know your formulation options: Discuss with your neurologist in advance whether the oral solution or a different tablet strength could work as a backup if your usual strength is unavailable.

Have a contingency plan: Ask your neurologist what to do if you can't fill your prescription. Having this conversation before a crisis is far less stressful than trying to reach your doctor in a panic.

What to Do Right Now If You Can't Find Keppra

If you're struggling to find levetiracetam right now, medfinder can call pharmacies near you to check current stock and text you the results. Also try independent pharmacies and grocery store pharmacies, which often have different supply chains than large chains.

If you absolutely cannot find it anywhere, contact your neurologist immediately. For guidance on what alternatives your doctor might consider, see our post on alternatives to Keppra if you can't fill your prescription.